Blue Cross Blue Shield is dedicated to maintaining local relationships to ensure they can provide the best care continuum to patients, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Blue Cross Blue Shield is dedicated to maintaining local relationships to ensure they can provide the best care continuum to patients, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Transcript
As the nation's largest health insurer, how does Blue Cross Blue Shield manage emerging innovations in oncology care and treatment?
We ensure 1 in 3 Americans—107 million people across the country, across a variety of insurance products, commercial and government programs. When we think about innovation, we think closely about how it aligns in a local market. We think about how providers and payers in those local markets and our local plans can work together to best use the innovation that's coming out of physician and hospital practices and facilities to really manage members across their care continuum and ensure that they're receiving the highest quality care. We then of course, use data and quality measurement to evaluate the overall value of that care. For us, what's important is really that local relationship and managing it at the patient and provider level.
What implemented innovations by Blue Cross Blue Shield in oncology care excite you the most?
We have some really great programs going on at the local level across the Blue's plans. I'd like to highlight 1 in particular, which is with US oncology and Blue Cross Blue Shield of Minnesota. They have worked very closely with that practice to manage various cancer types using quality measurement and have talked about ways to reduce the administrative burden. This really brings value into the equation as well as the care continuum managed across the medical neighborhood. We really do the very best that we can for those patients and their families.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More